Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103396429B reveals enzymatic synthesis of silicon chiral centers. Achieve >99% ee with mild conditions. Reliable supplier for cost reduction in fine chemical manufacturing.
Patent CN107382644A reveals a Pd-catalyzed route for high-purity chiral tertiary alcohols. Discover cost reduction in chiral drug manufacturing and supply advantages.
Novel preparation method for Nebivolol intermediates offers high yield and chiral purity. Reliable supply chain partner for pharmaceutical manufacturing.
Patent CN107721858B reveals a novel asymmetric α-benzoylation method. Discover cost-effective chiral intermediate manufacturing with recyclable catalysts for global supply chains.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN1642930A reveals an inorganic base-catalyzed method for high-purity CCR5 antagonist intermediates, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN116496214B reveals high-purity synthesis for atracurium intermediates. Discover cost-effective manufacturing and reliable supply chain solutions today.
Patent CN102951980A reveals a novel iridium-catalyzed method for producing chiral amines, offering significant cost reduction in agrochemical intermediate manufacturing and scalable supply chain solutions.
Patent CN118724766A details a high-purity L-glufosinate route. Offers cost reduction and scalable supply for agrochemical manufacturing partners.
Advanced patent-based synthesis for high-purity chiral phosphorus acid esters. Reduces impurities and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN101857887B enables high-purity aryl alcohol production. Reduced reaction time and cofactor costs ensure reliable supply chain performance.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Stable chiral intermediate synthesis via CN109851542A. Enhanced storage stability and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN102766058A details a novel organocatalytic route for photoactive alpha-amino acids, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN103483363A reveals a novel Cu-NHC catalyzed route for diverse chiral aminoboronic acids, offering high stereoselectivity and simplified manufacturing for API intermediates.
Patent CN113717910B details a novel tri-enzyme system for (S)-citronellol synthesis, offering superior selectivity and scalable production for the global fragrance industry.
Advanced synthesis of chiral 5-(4-fluorophenyl)-5-hydroxypentanoate via lactone intermediate. High purity Ezetimibe intermediate with scalable, cost-effective manufacturing.
Patent CN112481226B details solvent-tolerant ADH mutants for scalable production of chiral alcohols, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN107382644B details a novel Pd-B co-catalyzed asymmetric method for chiral tertiary alcohols, offering high ee and mild conditions for antifungal drug manufacturing.
Patent CN1068876C details a novel route for chiral succinic acid derivatives, offering improved purity and yield for pharmaceutical intermediates.